Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2

被引:23
|
作者
Zheng, Guangrong [1 ]
Dwoskin, Linda P. [1 ]
Deaciuc, Agripina G. [1 ]
Crooks, Peter A. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
Vesicular monoamine transporter; Lobelane; Structure-activity relationship;
D O I
10.1016/j.bmcl.2008.10.042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of lobelane homologues has been synthesized and evaluated for their [(3)H]DTBZ binding affinity at the vesicular monoamine transporter-2 (VMAT2). The structure-activity relationships (SAR) indicate that for retention of binding affinity at VMAT2, the lengths of the methylene linkers should be no shorter than one methylene unit at C-6 of the piperidine ring, and no shorter than two methylene units at C-2 of the piperidine ring. These results indicate that the intramolecular distances between the piperidine ring and two phenyl rings in lobelane analogues are an important criterion for retention of high affinity at VMAT2. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6509 / 6512
页数:4
相关论文
共 50 条
  • [1] Lobelane analogues as novel ligands for the vesicular monoamine transporter-2
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Zhu, J
    Jones, MD
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (12) : 3899 - 3909
  • [2] Synthesis and evaluation of a series of tropane analogues as novel vesicular monoamine transporter-2 ligands
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4463 - 4466
  • [3] Lobelane Inhibits Methamphetamine-Evoked Dopamine Release via Inhibition of the Vesicular Monoamine Transporter-2
    Nickell, Justin R.
    Krishnamurthy, Sairam
    Norrholm, Seth
    Deaciuc, Gabriela
    Siripurapu, Kiran B.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (02): : 612 - 621
  • [4] GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
    Horton, David B.
    Nickell, Justin R.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (02) : 177 - 186
  • [5] Variants of the primate vesicular monoamine transporter-2
    Jassen, AK
    Brown, JM
    Panas, HN
    Miller, GM
    Xiao, DQ
    Madras, BK
    MOLECULAR BRAIN RESEARCH, 2005, 139 (02): : 251 - 257
  • [6] TRANSPORT OF HISTAMINE BY VESICULAR MONOAMINE TRANSPORTER-2
    MERICKEL, A
    EDWARDS, RH
    NEUROPHARMACOLOGY, 1995, 34 (11) : 1543 - 1547
  • [7] Synthesis and evaluation of 2-amino-dihydroxytetrabenazine derivatives as probes for the vesicular monoamine transporter-2
    Zhu, Lin
    Liu, Jingying
    Kung, Hank F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [8] Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2
    Zhu, Lin
    Liu, Jingying
    Kung, Hank F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 5026 - 5028
  • [9] Ephedrine Decreases Vesicular Monoamine Transporter-2 Function
    Ellis, Jonathan D.
    German, Christopher L.
    Birdsall, Elisabeth
    Hanson, Jarom E.
    Crosby, Marcus A.
    Rowley, Shane D.
    Sawada, Nicole A.
    West, Jeremiah N.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2011, 65 (05) : 449 - 451
  • [10] Phenyl Ring-Substituted Lobelane Analogs: Inhibition of [3H]Dopamine Uptake at the Vesicular Monoamine Transporter-2
    Nickell, Justin R.
    Zheng, Guangrong
    Deaciuc, Agripina G.
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (03): : 724 - 733